PURPOSE: To evaluate relationships between retinal vessel caliber, AIDS-related factors, and mortality. DESIGN: Longitudinal, observational cohort study. METHODS: We evaluated data for participants without ocular opportunistic infections at initial examination (baseline) in the Longitudinal Studies of the Ocular Complications of AIDS (1998-2008). Semi-automated evaluation of fundus photographs (1 eye/participant) determined central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and arteriole-to-venule ratio (AVR) at baseline. Multiple linear regression models, using forward selection, identified independent relationships between indices and various host- and disease-related variables. RESULTS: Included were 1250 participants. Mean follow-up for determination of mortality was 6.1 years. Smaller CRAE was related to increased age (P < .001) and hypertension (P < .001); larger CRAE was related to lower hematocrit (P = .002). Larger CRAE and CRVE were associated with black race (P < .001). Larger CRVE was related to smoking (P = .004); smaller CRVE was related to age (P < .001) and higher mean corpuscular volume (P = .001). We observed the following relationships with AIDS-associated factors: smaller CRAE and larger CRVE with history of highly active antiretroviral therapy (HAART; P < .001); and larger CRAE with lower CD4+ T lymphocyte count (P = .04). We did not identify independent relationships with human immunodeficiency virus RNA blood levels. There was a 12% (95% CI, 2%-21%) increase in mortality risk per quartile of decreasing AVR (P = .02). CONCLUSIONS: Variations in retinal vascular caliber are associated with AIDS-specific factors and are markers for increased mortality risk. Relationships are consistent with the hypothesis that the vasculature is altered by known atherogenic effects of chronic HAART or the prolonged inflammatory state associated with AIDS. Copyright Â
PURPOSE: To evaluate relationships between retinal vessel caliber, AIDS-related factors, and mortality. DESIGN: Longitudinal, observational cohort study. METHODS: We evaluated data for participants without ocular opportunistic infections at initial examination (baseline) in the Longitudinal Studies of the Ocular Complications of AIDS (1998-2008). Semi-automated evaluation of fundus photographs (1 eye/participant) determined central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and arteriole-to-venule ratio (AVR) at baseline. Multiple linear regression models, using forward selection, identified independent relationships between indices and various host- and disease-related variables. RESULTS: Included were 1250 participants. Mean follow-up for determination of mortality was 6.1 years. Smaller CRAE was related to increased age (P < .001) and hypertension (P < .001); larger CRAE was related to lower hematocrit (P = .002). Larger CRAE and CRVE were associated with black race (P < .001). Larger CRVE was related to smoking (P = .004); smaller CRVE was related to age (P < .001) and higher mean corpuscular volume (P = .001). We observed the following relationships with AIDS-associated factors: smaller CRAE and larger CRVE with history of highly active antiretroviral therapy (HAART; P < .001); and larger CRAE with lower CD4+ T lymphocyte count (P = .04). We did not identify independent relationships with human immunodeficiency virus RNA blood levels. There was a 12% (95% CI, 2%-21%) increase in mortality risk per quartile of decreasing AVR (P = .02). CONCLUSIONS: Variations in retinal vascular caliber are associated with AIDS-specific factors and are markers for increased mortality risk. Relationships are consistent with the hypothesis that the vasculature is altered by known atherogenic effects of chronic HAART or the prolonged inflammatory state associated with AIDS. Copyright Â
Authors: David J Couper; Ronald Klein; Larry D Hubbard; Tien Yin Wong; Paul D Sorlie; Lawton S Cooper; Rosemary J Brothers; F Javier Nieto Journal: Am J Ophthalmol Date: 2002-01 Impact factor: 5.258
Authors: Lauren M Sherry; Jie Jin Wang; Elena Rochtchina; TienY Wong; Ronald Klein; LarryD Hubbard; Paul Mitchell Journal: Clin Exp Ophthalmol Date: 2002-06 Impact factor: 4.207
Authors: Michael D Knudtson; Kristine E Lee; Larry D Hubbard; Tien Yin Wong; Ronald Klein; Barbara E K Klein Journal: Curr Eye Res Date: 2003-09 Impact factor: 2.424
Authors: L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai Journal: Ophthalmology Date: 1999-12 Impact factor: 12.079
Authors: R Klein; A R Sharrett; B E Klein; L E Chambless; L S Cooper; L D Hubbard; G Evans Journal: Arterioscler Thromb Vasc Biol Date: 2000-06 Impact factor: 8.311
Authors: Milo A Puhan; Mark L Van Natta; Frank J Palella; Adrienne Addessi; Curtis Meinert Journal: Clin Infect Dis Date: 2010-10-15 Impact factor: 9.079
Authors: Tien Yin Wong; Ronald Klein; F Javier Nieto; Barbara E K Klein; A Richey Sharrett; Stacy M Meuer; Larry D Hubbard; James M Tielsch Journal: Ophthalmology Date: 2003-05 Impact factor: 12.079
Authors: Harry Leung; Jie Jin Wang; Elena Rochtchina; Ava G Tan; Tien Y Wong; Ronald Klein; Larry D Hubbard; Paul Mitchell Journal: Invest Ophthalmol Vis Sci Date: 2003-07 Impact factor: 4.799
Authors: T Y Wong; L D Hubbard; R Klein; E K Marino; R Kronmal; A R Sharrett; D S Siscovick; G Burke; J M Tielsch Journal: Br J Ophthalmol Date: 2002-09 Impact factor: 4.638
Authors: Dan Wang; Joseph K Melancon; Jennifer Verbesey; Haihong Hu; Chenglong Liu; Shakil Aslam; Mary Young; Christopher S Wilcox Journal: J AIDS Clin Res Date: 2013-12-01
Authors: Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs Journal: J Int Assoc Provid AIDS Care Date: 2013 Sep-Oct
Authors: Douglas A Jabs; Mark L Van Natta; Jeong Won Pak; Ronald P Danis; Peter W Hunt Journal: Invest Ophthalmol Vis Sci Date: 2018-02-01 Impact factor: 4.799
Authors: Douglas A Jabs; Mark L Van Natta; Garrett Trang; Norman Jones; Jeffrey M Milush; Ryan Cheu; Nichole R Klatt; Jeong Won Pak; Ronald P Danis; Peter W Hunt Journal: Invest Ophthalmol Vis Sci Date: 2019-05-01 Impact factor: 4.799
Authors: Sophia Pathai; Helen A Weiss; Stephen D Lawn; Tunde Peto; Leris M D'Costa; Colin Cook; Tien Y Wong; Clare E Gilbert Journal: PLoS One Date: 2012-12-10 Impact factor: 3.240